Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


6 BMC Cancer
9 Br J Dermatol
3 Cancer
1 Cancer Lett
4 Clin Exp Dermatol
8 Cutis
4 Int J Dermatol
2 J Cutan Pathol
3 J Dermatol
5 J Invest Dermatol
6 Lancet
1 Mycoses
1 N Engl J Med
1 Nat Rev Cancer
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Cancer

  1. ZHANG C, Liang Z, Liu W, Zeng X, et al
    Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    BMC Cancer. 2023;23:37.
    PubMed         Abstract available

  2. VERBEEK JGE, de Jong VMT, Wijnja HM, Jager A, et al
    High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.
    BMC Cancer. 2023;23:26.
    PubMed         Abstract available

  3. WANG AJ, McCann B, Soon WCL, De Ieso PB, et al
    Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre.
    BMC Cancer. 2023;23:30.
    PubMed         Abstract available

  4. DENG H, Wang L, Wang N, Zhang K, et al
    Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data.
    BMC Cancer. 2023;23:29.
    PubMed         Abstract available

  5. HUANG S, Yang Q, Zheng X, Chow KM, et al
    Predictors of surgery choices in women with early-stage breast cancer in China: a retrospective study.
    BMC Cancer. 2023;23:23.
    PubMed         Abstract available

  6. LIU S, Du S, Gao S, Teng Y, et al
    A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
    BMC Cancer. 2023;23:15.
    PubMed         Abstract available

    Br J Dermatol

  7. HE X, Shi H
    How does acral melanoma respond to immunotherapy?
    Br J Dermatol. 2022 Nov 10:ljac035. doi: 10.1093.

  8. YOTSU RR, Fuller LC, Murdoch ME, Revankar C, et al
    World Health Organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?
    Br J Dermatol. 2022 Oct 20:ljac031. doi: 10.1093.

  9. WITTLICH M, Westerhausen S, Strehl B, Versteeg H, et al
    The GENESIS-UV study on ultraviolet radiation exposure levels in 250 occupations to foster epidemiological and legislative efforts to combat nonmelanoma skin cancer.
    Br J Dermatol. 2022 Nov 11:ljac093. doi: 10.1093.
    PubMed         Abstract available

  10. MIDANDER K, Werner P, Isaksson M, Wisgrill L, et al
    Cobalt nanoparticles cause allergic contact dermatitis in humans.
    Br J Dermatol. 2022 Oct 28:ljac043. doi: 10.1093.
    PubMed         Abstract available

  11. ROSENO NAL, Lorup EH, Richardson C, Alarcon I, et al
    Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study.
    Br J Dermatol. 2022 Nov 11:ljac086. doi: 10.1093.
    PubMed         Abstract available

  12. BRAVO FG
    Assessing the use of biologic therapy for psoriasis in Latin America.
    Br J Dermatol. 2023 Jan 13:ljad003. doi: 10.1093.

  13. YUE W, Cheng D, Sun Z, Shen Y, et al
    Validation of diagnostic criteria for atopic dermatitis and proposal of novel diagnostic criteria for adult and elderly Chinese populations: a multicentre, prospective, clinical setting-based study.
    Br J Dermatol. 2022 Dec 12:ljac097. doi: 10.1093.
    PubMed         Abstract available

  14. HU C, Jansen PW
    Do adolescents with atopic dermatitis have lower cognitive function and school performance than their peers without atopic dermatitis?
    Br J Dermatol. 2022 Nov 29:ljac105. doi: 10.1093.

  15. CLAYTON K, Holbrook DJ, Vallejo A, Porter G, et al
    Skin programming of inflammatory responses to Staphylococcus aureus is compartmentalized according to epidermal keratinocyte differentiation status.
    Br J Dermatol. 2022 Nov 17:ljac088. doi: 10.1093.
    PubMed         Abstract available


  16. Collagen type XII linked with poor overall survival in breast cancer.
    Cancer. 2023;129:331-332.

  17. GU J, Tong T, Xu D, Cheng F, et al
    Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Cancer. 2022 Nov 19. doi: 10.1002/cncr.34540.
    PubMed         Abstract available

  18. AUGUSTIN RC, Luke JJ
    Top advances of the year: Melanoma.
    Cancer. 2023 Jan 11. doi: 10.1002/cncr.34590.

    Cancer Lett

  19. GANDULLO-SANCHEZ L, Pandiella A
    An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs.
    Cancer Lett. 2023;554:216024.
    PubMed         Abstract available

    Clin Exp Dermatol

  20. FEITO-RODRIGUEZ M, Ramirez-Bosca A, Vidal-Asensi S, Fernandez-Nieto D, et al
    Randomised double blind placebo controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and the use of corticosteroids in children and adolescents with atopic dermatitis.
    Clin Exp Dermatol. 2023 Jan 13:llad007. doi: 10.1093.
    PubMed         Abstract available

  21. LIM YT, Robinson S, Tang MM
    Liver Disease Among Patients with Psoriasis: The Malaysian Psoriasis Registry.
    Clin Exp Dermatol. 2023 Jan 12:llad013. doi: 10.1093.
    PubMed         Abstract available

  22. RUGGIERO A, Megna M, Caiazzo G, Parisi M, et al
    Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'.
    Clin Exp Dermatol. 2022 Dec 22:llac130. doi: 10.1093.

  23. KANJI A, Hussain K, Patel NP
    Opportunities for implementing a patient-initiated follow-up pathway for patients with psoriasis completing phototherapy.
    Clin Exp Dermatol. 2022 Dec 7:llac114. doi: 10.1093.
    PubMed         Abstract available


  24. DANESHBOD Y, Ahmed I, Kerstetter J
    Psoriasiform Dermatitis Associated With the Moderna COVID-19 Messenger RNA Vaccine.
    Cutis. 2022;110:E1-E4.

  25. MATTHEWS S, Young C, Litzner B
    Yellow Papules and Plaques on a Child.
    Cutis. 2022;110:262-269.

  26. HUNT MJ, Elston DM
    Botanical Briefs: Toxicodendron Dermatitis.
    Cutis. 2022;110:270-273.
    PubMed         Abstract available

  27. HAFT MA, Sui JY, Choi M, Eichenfield LF, et al
    Past, Present, and Future of Pediatric Atopic Dermatitis Management.
    Cutis. 2022;110:259-261.

  28. LYON PR, Burgess B, Berg EA, Fernandez MP, et al
    Cutaneous and Subcutaneous Perineuriomas in 2 Pediatric Patients.
    Cutis. 2022;110:277-280.
    PubMed         Abstract available

  29. COKER HB 4TH, Mountcastle EA
    Primary Malignant Melanoma of the Middle Ear.
    Cutis. 2022;110:E12-E14.

  30. LIO PA
    Dietary Triggers for Atopic Dermatitis in Children.
    Cutis. 2022;110:264-266.

  31. GUENTHER J, Johnson H, Yu J, Adler BL, et al
    Photoallergic Contact Dermatitis: No Fun in the Sun.
    Cutis. 2022;110:241-267.
    PubMed         Abstract available

    Int J Dermatol

  32. ALMUHANA G, Alsalhi A, Alsalhi H, Al-Hoqail IA, et al
    New insight into the management of toxic epidermal necrolysis following the coadministration of lamotrigine and valproic acid.
    Int J Dermatol. 2023 Jan 13. doi: 10.1111/ijd.16584.

  33. PETTIT C, Trinidad J, Chung C, Patterson A, et al
    Hospital triage and skin disease: hospital outcomes are differentially associated with cutaneous morphology.
    Int J Dermatol. 2023 Jan 13. doi: 10.1111/ijd.16575.
    PubMed         Abstract available

  34. YAMAMOTO T, Miura K, Eishi Y
    Detection of Propionibacterium acnes in cutaneous lichenoid sarcoidosis in a patient with Blau syndrome.
    Int J Dermatol. 2023 Jan 12. doi: 10.1111/ijd.16583.

  35. MODESTI CA, Alves JP, Leopoldo LR, Bonamigo RR, et al
    Segmental stiff skin syndrome: report of a rare disease.
    Int J Dermatol. 2023 Jan 11. doi: 10.1111/ijd.16577.

    J Cutan Pathol

  36. ROCCUZZO G, Avallone G, Cavallo F, Mastorino L, et al
    Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai Dorfman disease in distinct lesions: a unique association.
    J Cutan Pathol. 2023 Jan 13. doi: 10.1111/cup.14391.
    PubMed         Abstract available

  37. KOZERA EK, Langan R, Singh-Grewal D, Sun HY, et al
    Neonatal lupus erythematosus presenting as a non-bullous histiocytoid neutrophilic dermatosis.
    J Cutan Pathol. 2023 Jan 8. doi: 10.1111/cup.14387.
    PubMed         Abstract available

    J Dermatol

  38. NAKASHIMA C, Kato M, Otsuka A
    Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651.
    PubMed         Abstract available

  39. FUJITA Y, Sugai T, Maya Y, Inamura E, et al
    Secukinumab-induced oral lichen planus in a psoriatic arthritis patient ameliorated after a switch to risankizumab.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16719.
    PubMed         Abstract available

  40. TADA Y, Itakura A, Hosono K, Kawamura T, et al
    Psoriasis patient preferences for the use of biologics during the coronavirus era.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16703.
    PubMed         Abstract available

    J Invest Dermatol

  41. LIU W, Xu R, Wang F
    Recent Advances of Basophils in Pruritic Skin Diseases.
    J Invest Dermatol. 2023 Jan 4:S0022-202X(22)02889.
    PubMed         Abstract available

  42. GROLLEAU C, Calugareanu A, Demouche S, Nosbaum A, et al
    IL-4/IL-13 inhibitors for atopic dermatitis induce psoriatic rash transcriptionally close to pustular psoriasis.
    J Invest Dermatol. 2023 Jan 4:S0022-202X(22)02817.
    PubMed         Abstract available

  43. MENG Q, Bai M, Guo M, Li Z, et al
    Inhibition of serum and glucocorticoid-regulated protein kinase-1 aggravates imiquimod-induced psoriatic dermatitis and enhances proinflammatory cytokine expression via the NF-kappaB pathway.
    J Invest Dermatol. 2023 Jan 6:S0022-202X(23)00007.
    PubMed         Abstract available

  44. KANG T, Zhang C, Lei H, Luo R, et al
    NPTX2 Promotes EMT in Cutaneous Squamous Cell Carcinoma via Mettl3-Mediated m(6)A Methylation of Snail.
    J Invest Dermatol. 2023 Jan 10:S0022-202X(23)00009.
    PubMed         Abstract available

  45. AGARWAL A, Orlow SJ
    Skin in the Game: An Analysis of Venture Capital Investment in Dermatology from 2002 to 2021.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(22)02767.


  46. CHUA BH, Link EK, Kunkler IH, Olivotto IA, et al
    Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
    Lancet. 2023;401:24.

  47. MULLIEZ T, De Ridder M
    Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
    Lancet. 2023;401:23-24.

  48. MEROLA JF, Landewe R, McInnes IB, Mease PJ, et al
    Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-alpha inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
    Lancet. 2023;401:38-48.
    PubMed         Abstract available

  49. QUEIRO R
    Bimekizumab in psoriatic arthritis: a great leap forward?
    Lancet. 2023;401:2-3.

  50. MCINNES IB, Asahina A, Coates LC, Landewe R, et al
    Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
    Lancet. 2023;401:25-37.
    PubMed         Abstract available

  51. MITJA O, Ogoina D, Titanji BK, Galvan C, et al
    Lancet. 2023;401:60-74.
    PubMed         Abstract available


  52. GALILI E, Goldsmith T, Khanimov I, Arbel C, et al
    Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response.
    Mycoses. 2023;66:144-149.
    PubMed         Abstract available

    N Engl J Med

  53. TANG B, Chang X
    Condylomata Lata.
    N Engl J Med. 2023;388:e3.

    Nat Rev Cancer

  54. SENFT D
    Leptin fuels non-genetic skin tumour progression.
    Nat Rev Cancer. 2023 Jan 11. doi: 10.1038/s41568-023-00548.

    PLoS One

  55. DAMMU H, Ren T, Duong TQ
    Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients.
    PLoS One. 2023;18:e0280148.
    PubMed         Abstract available

  56. JI X, Chen H, Xie L, Chen S, et al
    The study of GSDMB in pathogenesis of psoriasis vulgaris.
    PLoS One. 2023;18:e0279908.
    PubMed         Abstract available

  57. WIJESOORIYA H, Samaranayake N, Karunaweera ND
    Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani.
    PLoS One. 2023;18:e0270722.
    PubMed         Abstract available

  58. YUAN Y, Liu X, Cai Y, Li W, et al
    Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review.
    PLoS One. 2023;18:e0279775.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.